NextCell Pharma AB (STO:NXTCL)

NextCell Pharma AB Revenue

NextCell Pharma AB had revenue of 2.26M SEK in the quarter ending May 31, 2025, a decrease of -8.89%. This brings the company's revenue in the last twelve months to 10.24M, down -24.72% year-over-year. In the fiscal year ending August 31, 2024, NextCell Pharma AB had annual revenue of 11.28M, down -19.18%.

• Revenue (ttm): 10.24M
• Revenue Growth: -24.72%
• P/S Ratio: 11.73
• Revenue / Employee: 426.62K
• Employees: 24
• Market Cap: 120.08M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Aug 31, 2024	11.28M	-2.68M	-19.18%
Aug 31, 2023	13.96M	7.73M	124.03%
Aug 31, 2022	6.23M	1.77M	39.82%
Aug 31, 2021	4.46M	288.92K	6.94%
Aug 31, 2020	4.17M	2.20M	112.11%